Encorafenib N-Oxide Impurity - Request Quote
Encorafenib N-Oxide Impurity
| SZ CAT No: | SZ-E056025 |
| CAS No | NA |
| Mol.F. | C22H27ClFN7O5S |
| Mol.Wt. | 556.0 |
| Inv. Status | Under Synthesis |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Encorafenib N-Oxide Impurity is chemically (S)-4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)-2-((2-((methoxycarbonyl)amino)propyl)amino)pyrimidine 1-oxide. Encorafenib N-Oxide Impurity is supplied with detailed characterization data compliant with regulatory guideline. Encorafenib N-Oxide Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Encorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Encorafenib N-Oxide Impurity
Purchase Encorafenib N-Oxide Impurity
Encorafenib N-Oxide Impurity suppliers
Encorafenib N-Oxide Impurity manufacturers
Encorafenib N-Oxide Impurity price
Order Encorafenib N-Oxide Impurity
Enquire Encorafenib N-Oxide Impurity
Encorafenib N-Oxide Impurity cost
Encorafenib N-Oxide Impurity Supplier
Encorafenib N-Oxide Impurity Distributor
Encorafenib N-Oxide Impurity for Method Validation
Encorafenib Reference Standard
Encorafenib N-Oxide Impurity for ANDA Filing
Encorafenib N-Oxide Impurity for Forced Degradation Studies
Encorafenib N-Oxide Impurity Identification Standards
Encorafenib N-Oxide Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.